Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Why Roku Stock May Surge Sky-High

By Chris Lau, InvestorPlace Contributor

Roku stock price may jump much higher. Analysts may fear ROKU's valuation,,but its prospects are better than ever.

MS Franchise, Spinraza Likely to Be Key Catalysts for Biogen Stock

By Chris Lau, InvestorPlace Contributor

The owners of Biogen stock will examine Biogen earnings to asss the progress that BIIB is making in key areas, including Ms and Spinraza.

Is Plug Power Stock Worth Gambling On?

By Chris Lau, InvestorPlace Contributor

Expect more volatility in PLUG stock ahead of its results, even though the latest acquisition looks promising for Plug Power stock.

Why Nio Still Has Huge Upside Despite the Recent Pull-Back

By Chris Lau, InvestorPlace Contributor

Profit-takers are sending Nio stock lower after the recent rally. Markets ignore the potentially great long-term prospects ahead.

The Future Just Looks Better and Better for Alibaba Stock

By Chris Lau, InvestorPlace Contributor

Alibaba stock bounced back in the last month. More upside follows as the company continues carrying out its growth strategy.

Load More